Concepedia

Effect of tralokinumab, an interleukin-13 neutralising monoclonal antibody, on eosinophilic airway inflammation in uncontrolled moderate-to-severe asthma (MESOS): a multicentre, double-blind, randomised, placebo-controlled phase 2 trial

Richard Russell, Latifa Chachi, J. Mark FitzGerald, Vibeke Backer, Ronald Olivenstein, Ingrid Louise Titlestad, Charlotte Suppli Ulrik, Timothy Harrison, Dave Singh, Rekha Chaudhuri,

The Lancet Respiratory Medicine · 2018 · 133 citations · 27 references

DOIFull text

Open access

Concepts

References

27

GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION

Romain Pauwels · Arerugī/Arerugi · 1996 · 10.1K citations

, , +10

International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

Kian Fan Chung, Sally E. Wenzel, Jan Brożek et al. · European Respiratory Journal · 2013 · 3.9K citations · Full text

, , +13

Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma

Héctor Ortega, Mark C. Liu, Ian Pavord et al. · New England Journal of Medicine · 2014 · 2.3K citations · Full text

, , +16

Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma

Pranabashis Haldar, Christopher E. Brightling, Beverley Hargadon et al. · New England Journal of Medicine · 2009 · 1.9K citations · Full text

, , +11

Lebrikizumab Treatment in Adults with Asthma

Jonathan Corren, Robert F. Lemanske, Nicola A. Hanania et al. · New England Journal of Medicine · 2011 · 1.5K citations

, , +12